Published in Gut on December 01, 2007
Recent advances in small bowel diseases: Part I. World J Gastroenterol (2012) 0.79
The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet (2001) 5.56
A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med (1995) 5.02
The role of psychological and biological factors in postinfective gut dysfunction. Gut (1999) 4.54
Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet (1996) 4.23
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology (2003) 3.77
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther (2003) 3.41
Defecation frequency and timing, and stool form in the general population: a prospective study. Gut (1992) 3.17
Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut (1983) 2.93
Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology (1988) 2.76
Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol (1999) 2.70
A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology (1984) 2.70
AGA technical review on Celiac Sprue. American Gastroenterological Association. Gastroenterology (2001) 2.53
Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut (2004) 2.48
Genetics of lactase persistence and lactose intolerance. Annu Rev Genet (2003) 2.34
Postinfectious irritable bowel syndrome. Gastroenterology (2003) 2.12
Diagnosis of giardiasis in infants and children by endoscopic brush cytology. J Pediatr Gastroenterol Nutr (1989) 2.11
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09
Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med (2000) 2.08
A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci (1989) 2.08
Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ (1999) 1.99
Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology (1990) 1.92
Ischemic colitis during treatment with alosetron. Gastroenterology (2001) 1.74
Bowel habit after cholecystectomy: physiological changes and clinical implications. Gastroenterology (1996) 1.68
Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut (2004) 1.56
Alterations of the colonic flora and their effect on the hydrogen breath test. Gut (1978) 1.51
Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire. Postgrad Med J (2002) 1.43
Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci (1984) 1.41
Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil (2003) 1.39
Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience. Aliment Pharmacol Ther (1994) 1.37
Giardiasis. Gastroenterol Clin North Am (1996) 1.35
Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment. Gut (1991) 1.33
Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Dig Dis Sci (1987) 1.23
Crohn's disease in Blackpool--incidence and prevalence 1968-80. Gut (1985) 1.21
Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology (1980) 1.21
Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol (1999) 1.14
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther (2001) 1.13
Giardiasis as a chronic disease. Dig Dis Sci (1985) 1.13
Symptom relief with amitriptyline in the irritable bowel syndrome. J Gastroenterol Hepatol (1998) 1.05
Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol (1994) 1.04
Review article: the management of Giardiasis. Aliment Pharmacol Ther (1999) 1.03
The relationship between psychosocial parameters and outcome in irritable bowel syndrome. Am J Med (1999) 1.02
Loperamide in treatment of irritable bowel syndrome--a double-blind placebo controlled study. Scand J Gastroenterol Suppl (1987) 1.01
Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci (2001) 1.01
Bowel habits and bile acid malabsorption in the months after cholecystectomy. Am J Gastroenterol (2002) 1.00
Microscopic colitis: epidemiology and treatment. Am J Gastroenterol (2003) 0.93
Lactose malabsorption in Greek adults: correlation of small bowel transit time with the severity of lactose intolerance. Gut (1982) 0.93
Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to cholestyramine. Aliment Pharmacol Ther (1998) 0.89
The clinical relevance of lactose malabsorption in irritable bowel syndrome. Eur J Gastroenterol Hepatol (1996) 0.88
Irritable bowel syndrome: is the search for lactose intolerance justified? Eur J Gastroenterol Hepatol (2001) 0.88
Tolerance to lactose among lactase-deficient American Indians. Gastroenterology (1978) 0.86
Review article: the complexity of drug development for irritable bowel syndrome. Aliment Pharmacol Ther (2002) 0.86
Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients. Am J Gastroenterol (2001) 0.85
Should cholecystectomy be combined with vagotomy and pyloroplasty? Lancet (1978) 0.85
Bile acid malabsorption in patients with post-vagotomy diarrhoea. Ann Chir Gynaecol (1992) 0.83
Is lactose intolerance implicated in the development of post-infectious irritable bowel syndrome or functional diarrhoea in previously asymptomatic people? Eur J Gastroenterol Hepatol (2002) 0.83
Value of bile-acid binding agents in post-vagotomy diarrhoea. Lancet (1978) 0.82
Glaxo Wellcome withdraws irritable bowel syndrome medication. FDA Consum (2002) 0.81
Effect of a single dose of lactase on symptoms and expired hydrogen after lactose challenge in lactose-intolerant subjects. Clin Pharm (1992) 0.80
A prospective study of persistent diarrhoea. Aust N Z J Med (1982) 0.79
Carbohydrate intolerance after acute gastroenteritis--a disappearing problem in Polish children. Acta Paediatr (1997) 0.77
Safety concerns about alosetron. Arch Intern Med (2002) 0.76
Gut in 2007. Gut (2007) 0.75